J Biol Chem, Vol. 274, Issue 36, 25869-25876, September 3, 1999
Stable Overexpression of Manganese Superoxide Dismutase in
Mitochondria Identifies Hydrogen Peroxide as a Major Oxidant in the
AP-1-mediated Induction of Matrix-degrading Metalloprotease-1*
Jutta
Wenk
,
Peter
Brenneisen
,
Meinhard
Wlaschek
,
Arndt
Poswig
,
Karlis
Briviba§,
Terry D.
Oberley¶, and
Karin
Scharffetter-Kochanek
From the
Department of Dermatology, University of
Cologne, 50931 Cologne, Germany, the § Department of
Physiological Chemistry, Heinrich Heine University, 40225 Düsseldorf, Germany, and the ¶ Department of Pathology,
University of Wisconsin, Madison, Wisconsin 53705
 |
ABSTRACT |
Reactive oxygen species (ROS) are important
second messengers for the induction of several genes in a variety of
physiological and pathological conditions. Here we addressed the
question of whether isolated, unbalanced overexpression of the
antioxidant enzyme manganese superoxide dismutase (Mn-SOD) may modulate
signal transduction cascades, finally leading to connective tissue
degradation, a hallmark in carcinogenesis and aging. Therefore, we
generated stably Mn-SOD-overexpressing fibroblasts with an up to
4.6-fold increase in Mn-SOD activity. The Mn-SOD-overexpressing cells
revealed specific resistance to the superoxide anion
(O
2)-generating agent paraquat, whereas no resistance to
UVA-generated oxidative stress was found. Treatment of the
Mn-SOD-overexpressing cells with various ROS-generating systems
resulted (due to the enhanced dismutation of superoxide anion to
hydrogen peroxide) in an up to 9.5-fold increase in matrix-degrading
metalloprotease-1 (MMP-1) mRNA levels. A similar increase in
MMP-1 mRNA was also seen when the intracellular H2O2 concentration was increased by
the inhibition of different H2O2-detoxifying
pathways. Furthermore, prooxidant conditions led to a strong induction
of c-jun and c-fos mRNA levels resulting in
a 4-fold higher transactivation of the transcription factor AP-1 in the
Mn-SOD-overexpressing cells. Collectively, we have found that enhanced
Mn-SOD activity, via an unbalanced H2O2
overproduction and detoxification, induces MMP-1 mRNA levels, and
this effect is at least partly mediated by the DNA recognition sequence
AP-1.
 |
INTRODUCTION |
Although reactive oxygen species are part of normal regulatory
circuits, imbalance or loss of cellular redox homeostasis results in
oxidative stress (1, 2), causing severe damage of cellular components.
Apart from permanent genetic changes involving protooncogenes and tumor
suppressor genes, reactive oxygen species
(ROS)1 activate cytoplasmatic
signal transduction pathways that are related to growth,
differentiation, senescence, and tissue degradation. Therefore, ROS
have been implicated to play a causal role in cancer, aging, and other
degenerative diseases like arteriosclerosis, osteoarthritis, and
impaired wound healing. These pathological states share unique features
and are all characterized by a dysregulated localized (as is the case
for cancer, invasion, and metastasis) or diffuse connective tissue
breakdown due to enhanced activity of various matrix-degrading
metalloproteases (3-10). The family of matrix-degrading
metalloproteases now comprises at least 19 members with partly
distinct, partly overlapping substrate specificities for different
extracellular matrix proteins of the connective tissue. Due to promoter
similarities, a variety of matrix-degrading metalloproteases (MMPs)
like the interstitial collagenase (MMP-1) (11) and stromelysin-1
(MMP-3) (12) have been shown to be similarly regulated in different
experimental settings. Accordingly, MMP-1 and MMP-3 have been found to
be induced upon UVA and UVB irradiation (13-15). The promoter of MMP-1
carries five AP-1 sites, and that of MMP-3 carries a single AP-1 site
(12), which are transactivated by binding of the newly synthesized and
heterodimerized Fos and Jun, which constitute the AP-1 transcription
factor (15, 16). Research on the regulation of the synthesis and
activity of transcription factors by endogenous and environmental
stimuli like ROS is a matter of increasing interest and relevance
(17-19), since it may provide ultimate clues for mechanisms underlying connective tissue degradation in pathological states. In fact, ROS have
been shown to transactivate transcription factors like NF-
B and AP-1
in carcinoma cell lines of epithelial origin (20, 21). Large efforts
have been made to better define the involvement of distinct ROS in
degenerative conditions to identify enzymes and molecules that can
scavenge oxygen radicals for their potential in the prevention and
therapy of these disorders.
To protect against oxidant injury, aerobic cells have evolved a
multilayered interdependent antioxidant system that includes enzymatic
and nonenzymatic components. The individual antioxidant enzymes are
located in specific subcellular sites and reveal distinct substrate
specificity. Among these, manganese superoxide dismutase (Mn-SOD) has
been the subject of particular interest because it is located in the
mitochondria and represents the first line of defense against
superoxide radicals produced as byproduct of oxidative phosphorylation,
upon UV 6irradiation and during immunological and nonimmunological
inflammatory processes. Mn-SOD can be induced by its substrate, the
superoxide anion itself, and appears to be involved in processes like
tumor suppression and cellular differentiation (22-26). Superoxide
anions are dismutated by Mn-SOD to hydrogen peroxide, which is
subsequently detoxified by catalase present in peroxisomes or by
glutathione peroxidase present in mitochondria and the cytosol.
Isolated overexpression or deficiencies of superoxide dismutases as
seen for the copper, zinc superoxide dismutase (Cu,Zn-SOD) in Down's
syndrome (trisomy 21) and amyotrophic lateral sclerosis is associated
with premature aging, neurodegeneration, and death (27, 28). Strong
interindividual differences in the spontaneous activity and
inducibility of Mn-SOD have been suggested to confer differences in the
individual susceptibility for the development of skin cancer and
metastasis (26).
Fibroblasts stably overexpressing Mn-SOD with a defined capacity for
the removal of superoxide anions and concomitant accumulation of
hydrogen peroxide were generated as well suited tools (1) to evaluate
the protective role of increased Mn-SOD activity in terms of resistance
to different oxidant injuries and (2) to further dissect the role of
distinct reactive oxygen species overproduced at defined subcellular
sites in signaling mechanisms underlying connective tissue degradation.
Stably transfected cell clones with an up to 4.6-fold overexpression of
Mn-SOD revealed specific resistance to superoxide anion-induced
cytotoxicity, while increased production of hydrogen peroxide, due to
enhanced dismutation of superoxide anion, resulted in a dramatic
induction of MMP-1. This hydrogen peroxide-dependent
9.5-fold induction of MMP-1 was found to be at least in part due to
enhanced c-fos and c-jun transcription and
subsequently enhanced transactivation of AP-1. Thus, isolated overexpression or stimulation of Mn-SOD without coordinate increase in
interdependent antioxidant enzymes working in the same detoxification pathway such as catalase and glutathione peroxidase results in an
intracellular increase in distinct ROS, which activate signal transduction pathways regulating the expression of transcription factors and effector genes related to connective tissue degradation.
 |
EXPERIMENTAL PROCEDURES |
Reagents--
Buthionine sulfoximine (BSO), an indirect
inhibitor of glutathione peroxidase (29); aminotriazole (ATZ), an
inhibitor of catalase (30); the iron chelator desferrioxamine (DFO)
(31); and the redox cycling agent paraquat (32) were obtained from Sigma (Deisenhofen, Germany). The MMP-1 probe used was a 920-base pair
(bp) HindIII/SmaI fragment of human collagenase
cDNA (33), the probe for c-jun was a 1400-bp
HindIII/BamHI fragment of the cDNA clone
hcJ-1 (34), and the probe for c-fos was an 800-bp BglII/NcoI fragment originally inserted in pUC 18 (35). A 24-mer oligonucleotide (5'-ACG GTA TCT GAT CGT CTT CGA ACC-3')
(36) for the 18 S rRNA was synthesized (Amersham Pharmacia Biotech, Freiburg, Germany).
Cell Cultures--
The human skin fibroblast cell line 1306 was
obtained from ECACC (Salisbury, United Kingdom; ECACC no. 90011887).
Cells were maintained in Dulbecco's modified Eagle's medium (Life
Technologies, Inc., Eggenstein, Germany) supplemented with 10% fetal
calf serum (Biochrom, Berlin, Germany), glutamine (2 mM),
penicillin (400 units/ml), and streptomycin (50 mg/ml) at 37 °C in a
humidified atmosphere of 5% CO2 and 95% air. Cells were
passaged at a 1:3 dilution every 3 days. Recombinant cells were
selected in neomycin (G 418) (Life Technologies) at 150 µg/ml, a
concentration that completely inhibited the growth of nontransfected cells.
Expression Vector for Human Mn-SOD and Cell
Transfection--
The 1.0-kilobase pair human Mn-SOD cDNA fragment
flanked by the EcoRI restriction site was inserted into the
EcoRI site of the expression vector pcDNA3 (Invitrogen,
San Diego, CA). The human liver Mn-SOD cDNA (37) (generously
provided by Dr. Jonathan Wispé of the Children's Hospital
Medical Center, University of Cincinnati, Cincinnati, OH) encodes the
entire 198-amino acid proprotein and includes 95 bp of the
5'-untranslated region and 216 bp of 3'-untranslated sequences. The
used expression vector contains the human cytomegalovirus major
intermediate early promoter/enhancer region and a neomycin resistance
marker for the selection of stable transfectants in the presence of
G418. The cytomegalovirus promotor is enhanced by the SV40 promoter.
Subconfluent cultures of the fibroblast cells 1306 were transfected
with the Mn-SOD expression vector (20 µg) by calcium-phosphate
precipitation (38) or by the transfection reagent LipofectAMINE (Life
Technologies). Both methods gave similar results. For selection of
stable transfectants, G418 (Life Technologies) was added to the cells
24 h after transfection. Individual neomycin-resistant cell clones
were screened by measuring Mn-SOD activity (Ref. 2; see below). Control
cells were transfected with the vector pcDNA3 alone and maintained
under identical conditions.
Assays for Determination of the Activity of Different Antioxidant
Enzymes--
All assays were performed with cells in a logarithmic
growth phase. The activity of SOD was detected by the nitro blue
tetrazolium reduction method according to Beauchamp and Fridovich (39). The inhibition by SOD of nitro blue tetrazolium in the aerobic xanthine/xanthine oxidase system was followed at 560 nm. One unit of
SOD corresponds to 50% inhibition of nitro blue tetrazolium reduction.
Mn-SOD activity was differentiated from Cu,Zn-SOD by its resistance to
5 mM cyanide. Catalase activity was measured by monitoring
the disappearance of H2O2 at 240 nm in the
presence of cellular lysates (40). Selenium-dependent
glutathione peroxidase was assayed using GSH and
t-butylhydroperoxide as substrate and monitoring GSSG
production through NADPH oxidation by glutathione reductase (41). The
phospholipid glutathione peroxidase activity was similarly determined
except that phosphatidylcholine hydroperoxide instead of
t-butylhydroperoxide was used (42). Protein content was
determined using Coomassie Blue with albumin as the standard (43).
Light Source and UV Irradiation--
The cells were irradiated
at a distance of 40 cm using a high intensity halogen metallide UVA
source (UVASUN®3000 equipped with the UVASUN® safety filters)
emitting wavelengths in the 340-450-nm range (Mutzhas, Munich,
Germany) (44). The spectral distribution of the UVASUN®3000 source
was determined with a Beckman UV 5270 spectral photometer. The incident
dose at the surface of the cells was 66 milliwatts/s. Dose rates were
monitored with a combined UVA/UVB ultravioletmeter (Centra-UV
dosimeter; Osram, Munich, Germany) (45). During irradiation, cells were
incubated in phosphate-buffered saline (PBS) and maintained at 37 °C
in a thermostatically controlled water bath. Following irradiation, PBS
was replaced by fresh medium with 10% fetal calf serum, and the cells
were incubated for various periods of time.
Cytotoxicity Assay--
The viability of the transfectants was
monitored 24 h after treatment with paraquat, UVA irradiation, or
incubation with BSO, ATZ, or DFO.
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
(Sigma) was used for the quantification of living metabolically active
cells. Mitochondrial dehydrogenases metabolize MTT to a purple formazan
dye, measured photometrically between 550 and 600 nm (46). Cytotoxicity
was calculated as the percentage of formazan formation in cells treated
under various conditions and chemical agents compared with mock-treated
cells. We intended to avoid interference of cytotoxicity from chemical
agents. Therefore, DFO was used at a nontoxic concentration of 10 µM, ATZ was used at 100 µM, and BSO was
used at 10 µM.
Determination of Hydrogen Peroxide Concentrations--
The
cellular release of hydrogen peroxide (H2O2)
into serum-free and dye-free media was assayed using a scopoletin
fluorescence assay. In this assay, H2O2
oxidizes up to 300 nM scopoletin to a nonfluorescent state
in a reaction catalyzed by 1 unit/ml horseradish peroxidase (47). The
decrease in fluorescence was measured using a Perkin-Elmer luminescence
spectrometer at an excitation wavelength of 340 nm. Emission was
measured at 460 nm. Plots were standardized with defined concentrations
of H2O2. The specificity of the generation and
release of H2O2 was tested by the addition of
catalase (4000 units/ml).
Electron Immunochemistry--
For specimen fixation and
embedding, cells were fixed in situ for 1 h in Carson
Millonig's fixative (4% formaldehyde in 0.16 M monobasic
sodium phosphate buffer, pH 7.2). Prior to embedding in medium grade LR
White (Electron Microscopy Science, Ft. Washington, PA), samples were
partially dehydrated in 70% ethanol with subsequent immersion and
infiltration in undiluted LR White resin. All dehydration and
infiltration steps with LR White were carried out at 25 °C. Resin
polymerization was thermally induced in sealed gelatin capsules at
45 °C for 48 h in the absence of any accelerator. Ultrathin sections (70-80 nm) were cut on a Sorvall MT2-B ultramicrotome with a
Diatome knife and subsequently transferred to 300-m nickel grids for
immunolabeling experiments.
Postembedding Immunocytochemistry--
For postembedding
immunogold procedure, sections were first incubated with 2% bovine
serum albumin, 0.2% Tween 20, and 0.06% sodium azide in Tris-buffered
saline (TBS; 0.05 M Tris base with 0.9% NaCl, pH 7.6) for
30-60 min at 4 °C to block nonspecific antibody binding and then
with rabbit polyclonal antihuman kidney Mn-SOD in TBS containing 1%
bovine serum albumin for 18 h at 4 °C. After briefly washing
the sections in TBS buffer (1:5 dilution of block buffer) and then in
TBS, pH 8.2, the sections were transferred to a 1:50 dilution of
gold-conjugated goat anti-rabbit IgG (Auroprobe, EM GAR G10; Amersham
Pharmacia Biotech) in TBS, pH 8.2, containing 0.1% bovine serum
albumin at ambient temperature for 60 min. The sections were further
washed in TBS, pH 8.2, fixed with 2.5% glutaraldehyde for 10 min,
washed extensively with double distilled water, and counterstained with
4% aqueous uranyl acetate for 10 min. Immunogold labeling was assessed
with a Philips 30 transmission electron microscope operated at 60 kV.
RNA Extraction and Northern Blot Analysis--
Total RNA was
isolated and analyzed by Northern blots using specific cDNA probes
or oligonucleotides for MMP-1, c-jun, c-fos, and
18 S ribosomal RNA for sequential hybridization (36, 48, 49). Briefly,
after extraction of total RNA, equal amounts of total RNA (5-20
µg/lane) were fractionated by size on a 0.9% 2.2 M
formaldhyde/agarose gel and blotted to nitrocellulose filters (Schleicher & Schuell). Hybridizations were performed using denatured 32P-labeled cDNA probes. For 3'-end labeling of the
24-mer 18 S ribosomal RNA probe, 5× terminal deoxynucleotidyl
transferase buffer (0.5 M potassium cacodylate, pH 7.2, 10 mM CoCl2, 1 mM dithiothreitol), 10 pmol of 3'-ends (80 ng of DNA of the 24-mer), 1.5 µCi of
[
-32P]dCTP/µl of reaction volume, and 1 unit/ml
terminal deoxynucleotidyl transferase (Life Technologies) were
incubated at 37 °C for 1 h. Densitometric analysis was
performed using the ScanPackII system (Biometra, Göttingen, Germany).
Transfection with CAT Reporter Gene Constructs and CAT
Enzyme-linked Immunosorbent Assay--
The collagenase CAT constructs
were kindly provided by Peter Angel (DKFZ, Heidelberg, Germany) and
have been described previously (50, 51). The
517/+63 CAT construct
contains the 5' control region of the collagenase gene reaching from
base
517 to +63 including an AP-1 binding sequence at positions
73
to
42, which is required for the induction of transcription by the
tumor promoter 12-O-tetradecanoylphorbol 13-acetate. The
517/+63 mutTRECollCAT construct contains a mutated TPA response
element between
72 and
65 (wild type,
74ATG AGT
CAG
66;
517/+63 TPA response element,
74AGT ACT CAG
66). The plasmid pCMV-
Gal
(CLONTECH, Heidelberg, Germany) was used as internal control. Cells
were plated at a density of 1.2 × 106 the day prior
to transfection. CAT reporter plasmids (25 µg) and the pCMV-
Gal
plasmid (2.5 µg) were cotransfected by calcium phosphate
precipitation (38) using a 2-min glycerol shock at 4 h after
treatment of cells with the calcium phosphate-DNA precipitate. Twelve h
after transfection, cells were washed twice with PBS and irradiated at
a dose of 300 kJ/m2 in PBS. Subsequently, the original
"preirradiation medium" was added back to the irradiated cells. For
control purposes, cultures were mock-treated. For the quantitation of
expressed CAT protein, cells were detached 30 h after transfection
with PBS, 10 mM EDTA; collected by centrifugation;
resuspended in 200 µl of 250 mM Tris-HCl (pH 7.8), 5 mM EDTA; and lysed by four freezing/thawing cycles. Fifty
mg of total cellular protein was assayed by a CAT enzyme-linked immunosorbent assay (Roche Molecular Biochemicals) according to the
manufacturer's instructions. Luciferase activity was determined in a
type 2010 luminometer (ALL, San Diego), using a commercial assay system
(Promega, Heidelberg, Germany). All transfections were performed in
duplicate and assayed at least three times.
 |
RESULTS |
Generation and Characterization of the Fibroblast Cell Line 1306 Stably Overexpressing Human Mn-SOD--
The human fibroblast cell line
1306 was transfected with the eukaryotic expression vector pcDNA3
containing the cDNA of human Mn-SOD and a neomycin resistance
cassette. Several G418-resistant cell clones were isolated. The Mn-SOD
activity of these clones was 2.2-4.6-fold increased compared with that
of the parental wild type 1306 cells and 1306 cells transfected with
the neomycin resistance expression vector pcDNA3 alone. The Mn-SOD
clones, Mn-SOD3 with a 4.6-fold increase, Mn-SOD12 with a 3.2-fold
increase, and Mn-SOD14 with a 2.5-fold increase in Mn-SOD activity were further studied as indicated. Increased expression of clone Mn-SOD3 did
not significantly alter the activities of other antioxidant enzymes including copper, zinc superoxide dismutase (Cu,Zn-SOD), catalase, glutathione peroxidase, and the phospholipid hydroperoxide glutathione peroxidase (Table 1).
To ascertain that the overexpressed Mn-SOD was properly transported
into the mitochondria, immunoelectron microscopy was performed using an
antibody against Mn-SOD (Fig. 1). Control
cells transfected with the neomycin resistance expression vector alone
revealed only low labeling (Fig. 1A). By contrast, the
Mn-SOD-transfected cell clone Mn-SOD3 revealed a strong labeling in
mitochondria, indicating that Mn-SOD is increased at their physiological site of production (Fig. 1B). There was very
low, slightly above background labeling in the extramitochondrial
cytosol. This low amount of extramitochondrial labeling may be due to
antibody detection of the Mn-SOD precursor form on its way from the
nucleus to the mitochondria. Substitution of the primary antibody by
normal rabbit serum did not show any immunolabeling in both control and Mn-SOD-expressing cells (data not shown). Overall, these data show that
in this system the overexpression of the recombinant Mn-SOD is
correctly routed and processed within the cells.
View this table:
[in this window]
[in a new window]
|
Table I
Activities of different antioxidant enzymes do not differ in
MnSOD-overexpressing cells compared with mock-transfected (V3) and
parental controls (1306 (wt))
The activities of antioxidant enzymes were spectrophotometrically
determined in cell homogenates as detailed under "Experimental
Procedures." Enzyme activities are expressed as units of activity/mg
of total protein. Each value is the mean ± S.D. of three
independent experiments.
|
|

View larger version (115K):
[in this window]
[in a new window]
|
Fig. 1.
Immunoelectronmicroscopy identified
overexpressed Mn-SOD in mitochondria. Immunogold labeling of
cultured 1306 fibroblasts was performed with the polyclonal rabbit
serum against human Mn-SOD and subsequent incubation with
gold-conjugated goat anti-rabbit IgG as described in detail under
"Experimental Procedures." In vector-transfected control cells
(V) only minor labeling was detected in mitochondria
(arrow), representing physiological expression of Mn-SOD
(A). In Mn-SOD-overexpressing 1306 cells (Mn-SOD3), a strong
labeling occurred in the mitochondrial matrix (arrow),
indicating that the overexpressed recombinant Mn-SOD is correctly
routed to the mitochondria (B). Original magnification
is × 17,000 (A) and × 18,000 (B)
M, mitochondrium.
|
|
Mn-SOD Overexpression Confers Cell Protection against Oxidant
Injury Induced by Paraquat but Not by UVA Irradiation--
UVA
irradiation and paraquat are known to intracellularly induce oxidative
stress. Upon UVA irradiation particularly, singlet oxygen, hydrogen
peroxide, and to a minor extent superoxide anions are generated, while
paraquat cytotoxicity is mainly due to the increased intracellular
production of superoxide anions. To determine whether an increase in
Mn-SOD activity protects against these different forms of oxidant
injury, two control cell clones, including 1306 cells transfected with
the neomycin resistance vector alone, and three Mn-SOD-overexpressing
cell clones were exposed to UVA irradiation at doses ranging from 100 to 1500 kJ/m2, and in a different set of experiments they
were exposed to paraquat at concentrations ranging from 200 to 750 µM. The tested Mn-SOD clones showed an increase in Mn-SOD
activity ranging from 2.5-fold (Mn-SOD14) to 3.2-fold (Mn-SOD12) and
4.6-fold (Mn-SOD3). Only modest alteration in viability of
Mn-SOD-overexpressing cells, as assessed by the MTT assay, was detected
upon UVA irradiation compared with the control cells (Fig.
2A). Apparently, the clones expressing 4.6- and 3.2-fold more Mn-SOD are slightly less viable in
response to high UVA doses of 1200 kJ/m2 (Fig.
2A). It is possible that the detoxification of UVA-generated superoxide anions to hydrogen peroxide adds to the overall hydrogen peroxide load directly generated by UVA irradiation, finally resulting in cytotoxic concentrations. High levels of hydrogen peroxide, in fact,
may drive the Fenton reaction resulting in the production of highly
toxic hydroxyl radicals. By contrast, treatment of Mn-SOD overexpressing cells with paraquat (Fig. 2B) resulted in a
significantly improved survival of cells exposed to paraquat at
different concentrations. At a lower paraquat concentration of 200 µM, Mn-SOD-overexpressing cells and control cells
revealed similar viability. The resistance of different
Mn-SOD-overexpressing cell clones to paraquat at higher concentrations
strongly correlated to the extent of Mn-SOD overexpression.
Accordingly, at a paraquat concentration of 500 µM, the
viability of the two vector-transfected controls was about 25%,
whereas the viability of the clone Mn-SOD14 (2.5-fold Mn-SOD overexpression) was 45%, that of clone Mn-SOD12 (3.2-fold
overexpression of Mn-SOD) was 58%, and the viability of the clone
Mn-SOD3 (4.6-fold Mn-SOD overexpression) was 65% of that of the
untreated cells.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 2.
Protection from cytotoxicity occurred in
Mn-SOD-overexpressing cells upon paraquat but not UVA exposure.
Confluent vector-transfected control cell clones ( , V3; , V19)
and cell clones overexpressing Mn-SOD at different levels ( ,
4.6-fold Mn-SOD-overexpressing cells (Mn-SOD3); , 3.2-fold
Mn-SOD-overexpressing cells (Mn-SOD12); , 2.5-fold
Mn-SOD-overexpressing cell clone (Mn-SOD14)) were UVA-irradiated at the
indicated doses (A) or were exposed to paraquat at the
indicated concentrations (B). The percentage of living cells
was measured 24 h post-treatment using the MTT assay. The
experiments were performed in triplicates in three independent
experiments; S.D. < 2%.
|
|
UVA Irradiation and Paraquat Treatment Increase Specific MMP-1
mRNA Levels in Mn-SOD-overexpressing Cells--
To study the
effect of Mn-SOD overexpression under different oxidative stress on
gene expression of MMP-1, the Mn-SOD-overexpressing cell clone Mn-SOD3
(Mn) was either exposed to UVA irradiation at a dose of 300 kJ/m2 or exposed to 150 µM paraquat,
conditions that have previously been shown to be nontoxic (Fig.
3). Total RNA was isolated at different
time points (6, 12, 24, and 48 h) post-treatment and subjected to
Northern blot analysis. UVA irradiation led to a marginal induction in
vector-transfected control cells V3 (V) at 6 h with a
maximal induction at 24 h post-treatment and a subsequent decrease
to basal levels. By contrast, exposure of Mn-SOD-overexpressing cells
(Mn) to UVA irradiation resulted in a 9.5-fold induction of
specific MMP-1 mRNA levels at 24 h compared with UVA
irradiated vector transfected control cells (V) (Fig.
3A). While vector-transfected control cells (V)
did not show any induction of MMP-1 mRNA levels even at a high
paraquat concentration of 400 µM, treatment of Mn-SOD-overexpressing cells (Mn) with a paraquat
concentration of 150 µM resulted already in a
time-dependent induction of MMP-1 mRNA levels with a
maximum at 24 h post-treatment. This induction was further
enhanced with a maximal induction at 48 h after exposure of cells
to paraquat at a concentration of 400 µM (Fig.
3B). These results suggest that the increase in MMP-1
mRNA levels upon exposure of Mn-SOD-overexpressing cells to
increasing superoxide anion (O
2) concentrations may be caused
by unbalanced production of hydrogen peroxide.

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 3.
UVA irradiation and paraquat resulted in a
stronger induction of MMP-1 mRNA levels in Mn-SOD-overexpressing
cells. Mn-SOD-overexpressing cells (Mn-SOD3) and vector control
cells (V3) were irradiated with a UVA source at a dose of 300 kJ/m2 (A) or treated with paraquat at the
indicated concentrations (B). Total RNA was isolated at 6, 12, 24, and 48 h post-treatment and subjected to Northern blot
analysis with sequential hybridization of specific probes for MMP-1 and
the 18 S ribosomal RNA (rRNA). The Northern blot reveals
representative data reproduced in three independent experiments.
|
|
Enhanced Spontaneous and Paraquat-induced Release of Hydrogen
Peroxide from Mn-SOD-overexpressing Cells--
Since all tested
Mn-SOD-overexpressing cell clones did not show any alteration in those
antioxidant enzymes responsible for further detoxification of hydrogen
peroxide (Table I), we hypothesized that hydrogen peroxide may
accumulate in Mn-SOD overexpressing cells. In order to test this
hypothesis, cells were analyzed for their release of hydrogen peroxide
into culture supernatants by the scopoletin/horseradish peroxidase
method. Both the spontaneous release of hydrogen peroxide and the
hydrogen peroxide release of cells exposed to the redox cycling
superoxide anion-generating agent paraquat were studied. As a
consequence of its higher superoxide anion dismutating capacity, the
clone Mn-SOD3 (Mn) showed an increase in the spontaneous
cellular hydrogen peroxide release of about 60% compared with the
parental cells 1306 and the control cells V3 (V) (Fig.
4A). Increasing the
intracellular O
2 concentration upon exposure of cells to 1 mM paraquat for 2 h resulted in a further increase in
hydrogen peroxide production (Fig. 4B).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 4.
Spontaneous and paraquat-induced
H2O2 release in supernatants is enhanced in
Mn-SOD-overexpressing cells. The rate of spontaneous
(A) and paraquat (PQ)-induced (B)
H2O2 release was determined in confluent
fibroblast cultures of the parental wild type 1306 cells
(wt), vector-transfected control cells (V), and
Mn-SOD-overexpressing cells (Mn) using the
scopoletin/horseradish peroxidase assay as described under
"Experimental Procedures." Hydrogen peroxide
(H2O2) release is expressed in pmol/1 × 106 cells. The values represent the mean of three
independent experiments with S.D. A and B, *,
p < 0.0001 compared with vector-transfected 1306 fibroblasts (V) (Student's t test).
|
|
Further Evidence for the Central Role of Increased Hydrogen
Peroxide Concentrations in the Induction of MMP-1 mRNA Levels--
We
have used a combined genetic and biochemical approach with stably
transfected Mn-SOD-overexpressing cells and inhibitors of
H2O2 detoxifying pathways to intracellularly
increase the concentration of H2O2. For this
purpose, we have incubated the clone Mn-SOD3 with ATZ, which inhibits
the catalase; BSO, which indirectly inhibits the glutathione
peroxidase; and DFO, an iron chelator, which blocks the
H2O2-consuming Fenton reaction (52). After
incubation of confluent monolayer cultures of the Mn-SOD-overexpressing
cell clone Mn-SOD3 (Mn) and the vector-transfected control
clone V3 (V) for 12 and 24 h with the above mentioned
chemical compounds, total RNA was isolated and subjected to Northern
blot analysis. In control cells of clone V3, no induction of MMP-1
mRNA levels could be detected upon treatment with different
chemical compounds (Fig. 5), suggesting
that a threshold concentration of hydrogen peroxide responsible for
MMP-1 induction has apparently not been reached. A low constitutive
expression of MMP-1 mRNA was detectable in untreated cells of the
Mn-SOD-overexpressing cell clone Mn-SOD3. Treatment of these cells with
ATZ, BSO, or DFO alone or in any combination resulted in a 15-fold
increase in the steady state levels of MMP-1 mRNA after 12 and
24 h. These data provide further evidence that intracellular
increase in hydrogen peroxide may play a major role in the induction of
MMP-1 mRNA levels.

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 5.
Modulation of steady-state mRNA levels of
MMP-1 in Mn-SOD-overexpressing and control cells by different pro- and
antioxidant compounds. Mn-SOD-overexpressing cells (Mn)
and vector-transfected control cells (V) were incubated with
ATZ, an inhibitor of catalase, and BSO, an indirect inhibitor of
glutathione peroxidase. Both agents led to a further increase in
intracellular hydrogen peroxide. Furthermore, Mn-SOD-overexpressing and
vector-transfected cells were incubated with the iron chelator DFO for
12 and 24 h to block the H2O2-consuming
Fenton reaction. Total RNA was isolated and subjected to Northern blot
analysis. Three independent experiments were performed showing the same
results as the presented blot. rRNA, ribosomal RNA.
|
|
UVA Induction of c-fos and c-jun Protooncogene Expression Is
Enhanced by Increased Intracellular H2O2
Concentrations--
The transcriptional induction of MMP-1 depends on
the transactivation of the AP-1 site, a DNA recognition sequence within the MMP-1 promoter. Transactivation of the AP-1 site occurs by binding
of newly synthesized and heterodimerized c-Jun and c-Fos, which
constitutes the AP-1 transcription factor. To examine whether increased
H2O2 concentrations may enhance the steady
state mRNA levels of c-fos and c-jun, the
Mn-SOD-overexpressing clone Mn-SOD3 (Mn) and the
vector-transfected control clone V3 (V) were UVA-irradiated or exposed to paraquat (Fig. 6).
Subsequently, specific c-jun and c-fos mRNA
levels were determined at different time points using Northern blot
analysis. Upon UVA irradiation, c-fos and c-jun
mRNA levels were increased 2- and 4-fold, respectively, in
Mn-SOD-overexpressing cells compared with vector-transfected cells with
similar induction kinetics, suggesting that
H2O2, in fact, enhances UVA induction of
c-fos and c-jun mRNA levels (Fig. 6). Similar
results were obtained following exposure of Mn-SOD-overexpressing cells
to 150 µM paraquat (data not shown).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 6.
mRNA levels of c-fos and
c-jun are stronger expressed upon UVA irradiation of
Mn-SOD-overexpressing cells compared with control cells. Time
course analysis of c-jun and c-fos steady state
mRNA levels following UVA irradiation at a dose of 300 kJ/m2 of Mn-SOD-overexpressing cells (Mn) and
vector-transfected control cells (V) was studied by Northern
blot analysis with sequential hybridization of cDNA probes for
c-fos, c-jun, and 18 S ribosomal RNA
(rRNA). The Northern blot reveals representative data
reproduced in two independent experiments.
|
|
Increased Intracellular H2O2 Concentration
Enhances the UVA Transactivation of AP-1--
To test whether the
enhanced induction of c-jun and c-fos mRNA
levels in Mn-SOD-overexpressing cells may result in enhanced transactivation of AP-1 preceding MMP-1 induction, the
Mn-SOD-overexpressing cell clone Mn-SOD3 (Mn) and the
vector-transfected control cells V3 (V) were transiently
transfected with a CAT reporter construct under the control of the
MMP-1 promoter. This construct contains the sequence
517 to +63
within the MMP-1 promoter including the AP-1 site located between
positions
73 and
42. Normalization of the transfection efficiency
was obtained by cotransfection with the
-galactosidase gene. Only a
low basal level of CAT expression was observed in the mock-treated
control and Mn-SOD-overexpressing cells. After UVA irradiation at a
dose of 300 kJ/m2 a 2-fold induction of CAT protein
occurred in the vector-transfected control cells (V) (Fig.
7), while a stronger 4-fold increase in CAT protein was obtained in Mn-SOD-overexpressing cells upon UVA irradiation. No induction of CAT protein occurred in cells transfected with a mutated AP-1 site construct (
AP-1). These data suggest that
increased H2O2 levels, most likely via enhanced
c-jun transcription, result in enhanced transactivation of
AP-1, which is at least in part responsible for a stronger MMP-1
induction in Mn-SOD-overexpressing cells compared with control cells
following UVA irradiation.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 7.
UVA irradiation results in stronger
transactivation of AP-1 in Mn-SOD-overexpressing cells compared with
control cells. Stably Mn-SOD-overexpressing cells (Mn)
and vector-transfected control cells (V) were transfected
with plasmids containing a CAT gene either driven by a MMP-1 promoter
( 517/+63 TREColl CAT (AP-1) or driven by a MMP-1 promoter containing
a mutated AP-1 site ( 517/+63 TRECollCAT ( AP-1)). The
transfected cells were UVA-irradiated at a dose of 300 kJ/m2 and assayed for the amount of synthesized CAT protein
by a specific enzyme-linked immunosorbent assay as detailed under
"Experimental Procedures." CAT expression was normalized to
-galactosidase expression. The data represent the mean of three
independent experiments. S.D. was < 10%; *, p = 0.0023 compared with vector-transfected 1306 fibroblasts (V)
(Student's t test).
|
|
 |
DISCUSSION |
In this study, we addressed the question of whether unbalanced
overexpression of the antioxidant enzyme Mn-SOD in response to various
oxidants may modulate signal transduction cascades and activate
cellular responses, finally leading to connective tissue degradation, a
hallmark in carcinogenesis, aging, and other pathological states. For
this purpose, we have generated stably transfected fibroblast cell
lines with isolated, unbalanced overexpression of Mn-SOD. We found that
unbalanced Mn-SOD overexpression significantly modulates the cellular
response to different oxidants in that Mn-SOD overexpression conferred,
as expected, protection to the cytotoxic action of the
superoxide-generating herbicide paraquat. By contrast, the
Mn-SOD-overexpressing cells revealed no significant protection from UVA
irradiation, which exerts its cytotoxicity mainly via singlet oxygen
(53). Furthermore, the unbalanced Mn-SOD overexpression with
subsequent intracellular accumulation of hydrogen peroxide was
identified to initiate and enhance early events in the complex
downstream signaling after exposure to UVA irradiation or paraquat,
finally leading to a 9.5-fold induction of MMP-1 mRNA levels. MMPs
and reactive oxygen species play a major role in the multistage process
of carcinogenesis and aging (54, 55). In fact, MMP-1 (interstitial
collagenase) and MMP-3 (stromelysin-1) are overexpressed during
invasion and metastasis in a variety of tumors including nonmelanoma
and melanoma skin cancer (56). Epidermis-specific overexpression of
MMP-1 in a transgenic mouse model results in an overall higher tumor
susceptibility and appears to be involved in the initiation of
tumorigenesis (57). Furthermore, aging characterized by severe
connective tissue degradation has been linked to induced synthesis and
activity of different members of the matrix-degrading metalloprotease
family (15, 58, 59, 61). Recent data suggest dysregulation of matrix-degrading metalloproteases to be causally involved in the development and perpetuation of osteoarthritis, impaired wound healing,
and arteriosclerosis (62-64).
Under physiological conditions, ROS are part of normal regulatory
circuits, and the cellular redox state is tightly controlled by
antioxidants. However, increased concentrations of ROS and loss of
cellular redox homeostasis, as in the case in unbalanced expression of
an isolated antioxidant enzyme, can be tumorigenic and promote
premature aging. We were recently able to establish a causal
relationship between increased production of distinct reactive oxygen
species and enhanced MMP-1 mRNA levels (52, 66). In this context,
it is interesting that tumor cells, due to unbalanced activity of
antioxidant enzymes (67), generate higher levels of reactive oxygen
species and reveal a higher invasive potential, most likely due to
ROS-dependent induction of MMPs with subsequent breakdown
of the peritumoral connective tissue (68). The major finding of this
report is that unbalanced overexpression of Mn-SOD with accumulation of
intracellular hydrogen peroxide results in a dramatically increased
induction of steady state mRNA levels of MMP-1 with specific
up-regulation of defined key steps in the signaling pathway of MMP-1.
In fact, this is the first report on enhanced MMP-1 induction due to an
imbalance of interdependent antioxidant enzymes. This may be of
particular relevance for the understanding of tumor susceptibility and
tumor progression. There are several examples for the detrimental
effects of imbalances in interdependent antioxidant enzymes occurring in genetic disorders, transgenic organisms, and cell biology (27, 28,
69). The most prominent example is Down's syndrome (trisomy 21) with
an aberration in chromosome 21. The copper, zinc superoxide dismutase
(Cu,Zn-SOD) is localized on chromosome 21, and due to increased gene
dosage its activity is increased with no compensatory increase in the
activities of the interdependent catalase or glutathione peroxidase.
These individuals with trisomy 21 suffer from premature aging, and
their fibroblasts reveal typical morphological and functional features
of postmitotic senescent cells (70). Furthermore, the complete absence
of Mn-SOD results in perinatal lethality (27). Hence, effective
cellular protection requires a balance between interdependent
antioxidant enzymes with an appropriate relationship to each other.
Further in vivo support comes from studies on double
transgenic Drosophila with overexpression of interdependent
antioxidant enzymes revealing substantial protection against
oxidant-dependent injury and an overall increase in
organismic lifespan (71).
Here, we have used different strategies to increase the intracellular
hydrogen peroxide concentration to study its effect on key steps in the
regulation of steady state mRNA levels of matrix-degrading enzymes.
Accordingly, we have generated Mn-SOD-overexpressing cell clones with
increased spontaneous release of hydrogen peroxide, which was further
enhanced when these cells were challenged by different oxidants like
paraquat or UVA irradiation. Moreover, we have used different
inhibitors and chemical compounds to block all hydrogen
peroxide-detoxifying pathways including inhibition of catalase,
glutathione peroxidase, and the hydrogen peroxide-consuming Fenton
reaction, thus further increasing hydrogen peroxide in Mn-SOD-overexpressing cells. In all of these experimental settings, we
found MMP-1 mRNA levels to be up to 9.5-fold increased compared with vector-transfected control cells, indicating that hydrogen peroxide as suggested previously (66) plays a major role in the
induction of MMP-1. These results are of considerable interest because
they imply potential caveats in the uncritical use of therapeutic
antioxidant strategies. It remains to be seen whether co-expression of
catalase could correct the unbalanced hydrogen peroxide levels and the
subsequent MMP-1 induction in Mn-SOD-overexpressing cells. To further
dissect regulatory effects of Mn-SOD overexpression on the induction of
MMP-1, specific mRNA levels of c-fos and
c-jun, as well as their transactivating effect on the AP-1
site within the MMP-1 promoter were studied. We focused on these
regulatory key steps because it was shown that induction of AP-1, a
heterodimer of Jun and Fos proteins, primarily relies on de
novo synthesis of these two DNA binding and transactivating
subunits. We found that UVA irradiation of Mn-SOD-overexpressing cells
with subsequently increased hydrogen peroxide levels resulted in a
marked increase in the inducibility of c-jun and, to a
lesser extent, of c-fos mRNA levels and furthermore
resulted in a significant increase in transactivation of the AP-1
site-containing MMP-1 promoter CAT construct. A variety of reports
have outlined the regulatory effects of reactive oxygen species in the
expression of several genes including c-fos and
c-jun (72-74). However, in these studies a potential role
for imbalances in the enzymatic antioxidant defense has not been addressed.
Although we did not provide direct evidence, the observed increase in
the steady state c-fos and c-jun mRNA levels
in Mn-SOD-overexpressing cells are most likely due to phosphorylation
of preexisting transcription factors, like the ternary complex factor
or the c-Jun/ATF2 (activating transcription factor) by defined kinase
families (75, 76). In fact, there is some evidence that reactive
oxygen species are involved in the activation of extracellular
stimulus-responsive kinases and Jun N-terminal kinases preceding the
phosphorylation of the ternary complex factor, which together with the
serum response factor activates c-fos transcription,
and of the c-Jun-ATF2 complex, which in its phosphorylated form
initiates c-jun transcription (52, 77).
The observed discrepancy between the 9.5-fold induction of MMP-1
mRNA levels and the weaker 4-fold induction of
AP-1-dependent CAT activity in Mn-SOD-overexpressing cells
upon UVA irradiation points to the possibility that besides
transcriptional regulation of AP-1 other mechanisms and/or
transcription factors may be involved in the enhanced inducibility of
MMP-1 mRNA levels. In fact, the relatively weak activation of AP-1
under oxidative conditions is not an unprecedented observation (21, 73,
79-81). In this context, it is most interesting that DNA binding and
transactivation of NF-
B and PEA3 have earlier been shown to
cooperate with AP-1 sites in MMP transcription (82, 83). In fact, Stein
et al. (84) have demonstrated that Fos and Jun proteins are
capable of physiologically interacting with NF-
B p65 through a Rel
homology domain with subsequent enhanced DNA binding and
transactivation via the
B and the AP-1 response elements. The exact
biophysical and molecular mechanisms underlying signal transduction
induced by reactive oxygen species are as yet unknown. Possible
mechanisms include oxidant-macromolecule interaction, alteration in the
overall and local cellular redox status, and calcium signaling (85). Also, the upstream signaling steps preceding the induction of activity
of Jun N-terminal kinase and extracellular stimulus-responsive kinase,
c-jun, c-fos, and MMP-1 mRNA levels after
oxidative challenge of Mn-SOD-overexpressing cells and the potential
involvement of cytokine networks in these processes (65, 78, 86, 87) have not been elucidated. However, there are some indications that
activation of AP-1 is mediated by membrane-associated Src-tyrosine kinases and Ha-Ras GTP-binding proteins after UVC irradiation (60).
Our data are consistent with a model whereby ROS preferentially
initiate the transcription of c-fos and c-jun
(75, 76). Here, we corroborate and extend these data and, in addition,
provide the first evidence that unbalanced enzymatic antioxidant
defense with subsequent intracellular accumulation of hydrogen peroxide drives the accumulation of c-jun mRNA and, in their
heterodimerized form, the enhanced transactivation of AP-1. However,
our experiments do not allow us to distinguish whether enhanced steady
state MMP-1 mRNA levels are due to enhanced transcription, enhanced
mRNA stability, or a combination thereof. Overall, our results
perfectly fit with an earlier published model for the role of increased
load of reactive oxygen species in carcinogenesis (69) and connective
tissue disorders in that imbalances in the interrelated and
interdependent antioxidant enzymes drive the accumulation of
intracellular ROS, as in our case hydrogen peroxide, which subsequently
activates signal transduction pathways and modulates the activity of
genes that regulate effector genes related to tissue degradation.
Further understanding may provide therapeutical approaches to
substitute and balance antioxidant deficiencies in pathological states.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of
Dermatology, University of Cologne, Josef-Stelzmann-Str. 9, 50931 Cologne, Germany. Tel.: 49-221-478-5086 (or -4517); Fax:
49-221-478-5949; E-mail: Karin.Scharffetter@uni-koeln.de.
 |
ABBREVIATIONS |
The abbreviations used are:
ROS, reactive oxygen
species;
ATZ, aminotriazole;
BSO, buthionine sulfoximine;
CAT, chloramphenicol acetyltransferase;
SOD, superoxide dismutase;
Cu,Zn-SOD, copper, zinc SOD;
Mn-SOD, manganese superoxide dismutase;
H2O2, hydrogen peroxide;
MMP, matrix-degrading
metalloprotease;
MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide;
O
2, superoxide anion;
DFO, desferrioxamine;
bp, base pair(s);
PBS, phosphate-buffered saline;
TBS, Tris-buffered saline.
 |
REFERENCES |
| 1.
|
Sies, H.
(1986)
Angew. Chemie
25,
1058-1071
[CrossRef] |
| 2.
|
Sies, H.
(1991)
Oxidative Stress: Oxidants and Antioxidants
, Academic Press, Inc., New York
|
| 3.
|
Gallagher, R. P.,
Elwood, J. M.,
and Yang, C. P.
(1989)
Int. J. Cancer
44,
813-815[Medline]
[Order article via Infotrieve]
|
| 4.
|
Henriksen, T.,
Dahlback, A.,
Larsen, S. H. H.,
and Maan, J.
(1990)
Photochem. Photobiol.
51,
579-582[Medline]
[Order article via Infotrieve]
|
| 5.
|
Kraemer, K. M.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
94,
11-14[Free Full Text]
|
| 6.
|
Urbach, F.
(1989)
Photochem. Photobiol.
50,
507-514[Medline]
[Order article via Infotrieve]
|
| 7.
|
Scharffetter-Kochanek, K.,
Wlaschek, M.,
Brenneisen, P.,
Schauen, M.,
Blaudschun, R.,
and Wenk, J.
(1997)
Biol. Chem.
378,
1247-1257
[Medline]
[Order article via Infotrieve] |
| 8.
|
Moulton, P. J.
(1996)
Br. J. Biomed. Sci.
53,
317-324[Medline]
[Order article via Infotrieve]
|
| 9.
|
Halliwell, B.
(1989)
Br. J. Exp. Pathol.
70,
737-757[Medline]
[Order article via Infotrieve]
|
| 10.
|
Cheatle, T.
(1991)
Br. J. Dermatol.
124,
508[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Aho, S.,
Rouda, S.,
Kennedy, S. H.,
Qin, H.,
and Tan, E. M. L.
(1997)
Eur. J. Biochem.
247,
503-510[Medline]
[Order article via Infotrieve]
|
| 12.
|
Sawamura, D.,
Ohta, T.,
Hanada, K.,
Ishikawa, H.,
Tamai, K.,
Mauviel, A.,
and Uitto, J.
(1996)
Arch. Dermatol. Res.
288,
628-632[Medline]
[Order article via Infotrieve]
|
| 13.
|
Herrmann, G.,
Wlaschek, M.,
Lange, T. S.,
Prenzel, K.,
Goerz, G.,
and Scharffetter-Kochanek, K.
(1993)
Exp. Dermatol.
2,
92-97[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Brenneisen, P.,
Oh, J.,
Wlaschek, M.,
Wenk, J.,
Briviba, K.,
Hommel, C.,
Herrmann, G.,
Sies, H.,
and Scharffetter-Kochanek, K.
(1996)
Photochem. Photobiol.
64,
649-657[Medline]
[Order article via Infotrieve]
|
| 15.
|
Fisher, G. J.,
Datta, S. C.,
Talwary, H. S.,
Wang, Z.-Q.,
Varani, J.,
Kang, S.,
and Voorhees, J. J.
(1996)
Nature
379,
335-339[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Angel, P.,
Imagawa, M.,
Chiu, R.,
Stein, B.,
Imbra, R. J.,
Rahmsdorf, H. J.,
Jonat, C.,
Herrlich, P.,
and Karin, M.
(1987)
Cell
49,
729-739[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Jahnknecht, R.,
and Hunter, T.
(1997)
J. Biol. Chem.
272,
4219-4224[Abstract/Free Full Text]
|
| 18.
|
Lo, Y. Y. C.,
Wong, J. M. S.,
and Cruz, T. F.
(1996)
J. Biol. Chem.
271,
15703-15707[Abstract/Free Full Text]
|
| 19.
|
Lee, S. F.,
Huang, Y. T.,
Wu, W. S.,
and Lin, J. K.
(1996)
Free. Radical Biol. Med.
21,
437-448[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Schmidt, K. N.,
Traenker, E. B.-M.,
Meier, B.,
and Baeuerle, P. A.
(1995)
J. Biol. Chem.
270,
27136-27142[Abstract/Free Full Text]
|
| 21.
|
Meyer, M.,
Schreck, R.,
and Baeuerle, P. A.
(1993)
EMBO J.
12,
2005-2015[Medline]
[Order article via Infotrieve]
|
| 22.
|
Harris, C. A.,
Derbin, K. S.,
Hunte-McDonough, B.,
Krauss, M. R.,
Chen, K. T.,
Smith, D. M.,
and Epstein, L. B.
(1991)
J. Immunol.
147,
149-154[Abstract]
|
| 23.
|
Sato, M.,
Sasak, M.,
and Hojo, H.
(1995)
Arch. Biochem. Biophys.
316,
738-744[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Akashi, M.,
Hachiya, M.,
Paquette, R. L.,
Osawa, Y.,
Shimizu, S.,
and Suzuki, G.
(1995)
J. Biol. Chem.
270,
15864-15869[Abstract/Free Full Text]
|
| 25.
|
St. Clair, D. K.,
Oberley, T. D.,
Muse, K. E.,
and St. Clair, W. H.
(1994)
Free Radical Biol. Med.
16,
275-282[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Poswig, A.,
Wenk, J.,
Brenneisen, P.,
Wlaschek, M.,
Hommel, C.,
Quel, G.,
Faisst, K.,
Dissemond, J.,
Briviba, K.,
Krieg, T.,
and Scharffetter-Kochanek, K.
(1999)
J. Invest. Dermatol.
112,
13-18[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Li, Y.,
Huang, T.-T.,
Carlson, E. J.,
Melov, S.,
Ursell, P. C.,
Olson, J. L.,
Noble, L. J.,
Yoshimura, M. P.,
Berger, C.,
Chan, P. H.,
Wallace, D. C.,
and Epstein, C. J.
(1995)
Nat. Genet.
11,
376-381[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
de Haan, J. B.,
Christiano, F.,
Ianello, R. C.,
Bladier, C.,
Kelner, M. J.,
and Kola, I.
(1996)
Hum. Mol. Genet.
5,
283-292[Abstract/Free Full Text]
|
| 29.
|
Tyrrell, R. M.
(1991)
in
Oxidative Stress: Oxidants and Antioxidants
(Sies, H., ed)
, pp. 57-83, Academic Press, Inc., New York
|
| 30.
|
Inoue, S.,
Ito, K.,
Yamamoto, K.,
and Kawanishi, S.
(1992)
Carcinogenesis
13,
1497-1502[Abstract/Free Full Text]
|
| 31.
|
Singh, S.,
and Hider, R. C.
(1994)
in
Free Radical Damage and Its Control
(Rice-Evans, C. A.
, and Burdon, R. H., eds)
, pp. 189-216, Elsevier, Amsterdam
|
| 32.
|
Kadiiska, M. B.,
Hanna, P. M.,
and Mason, R. P.
(1993)
Toxicol. Appl. Pharmacol.
123,
187-192[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Angel, P.,
Rahmsdorf, H. J.,
Pöting, A.,
Lücke-Huhle, C.,
and Herrlich, P.
(1985)
J. Cell. Biochem.
29,
351-360[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Angel, P.,
Allegretto, E. A.,
Okino, S. T.,
Hattori, K.,
Boyle, W. J.,
Hunter, T.,
and Karin, M.
(1988)
Nature
332,
166-171[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Angel, P.,
Smeal, T.,
Meek, J.,
and Karin, M.
(1989)
New. Biol.
1,
35-43[Medline]
[Order article via Infotrieve]
|
| 36.
|
Carlson, S. G.,
Fawcett, T. W.,
Bartlett, J. D.,
Bernier, M.,
and Holbrook, N. J.
(1993)
Mol. Cell. Biol.
13,
4736-4744[Abstract/Free Full Text]
|
| 37.
|
Wispe, J. R.,
Clark, J. C.,
Burhans, M. S.,
Kropp, K. E.,
Korfhagen, T. R.,
and Whitsett, J. A.
(1989)
Biochim. Biophys. Acta
994,
30-36[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Graham, F.,
and van der Eb, A.
(1973)
Virology
52,
456-467[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Beauchamp, C.,
and Fridovich, I.
(1971)
Anal. Biochem.
44,
276-287[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Aebi, H.
(1985)
Methods Enzymol.
105,
121-126
|
| 41.
|
Flohe, L.,
and Günzler, W. A.
(1984)
Methods Enzymol.
105,
114-121[Medline]
[Order article via Infotrieve]
|
| 42.
|
Maiorino, M.,
Chu, F. F.,
Ursini, F.,
Davies, K. J. A.,
Doroshow, J. H.,
and Esworthy, S. R.
(1991)
J. Biol. Chem.
266,
7728-7732[Abstract/Free Full Text]
|
| 43.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Mutzhas, M. F.,
Hölzle, E.,
Hofmann, C.,
and Plewig, G.
(1981)
J. Invest. Dermatol.
76,
42-47[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Lehmann, P.,
Hölzle, E.,
von Krus, R.,
and Plewig, G.
(1986)
Zentralblatt Haut
152,
667-682
|
| 46.
|
Green, L. M.,
Reade, J. L.,
and Ware, C. F.
(1984)
J. Immunol. Methods
70,
257-268[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Szatrowski, T. P.,
and Nathan, C. F.
(1991)
Cancer Res.
51,
794-798[Abstract/Free Full Text]
|
| 48.
|
Herrmann, G.,
Wlaschek, M.,
Lange, T. S.,
Prenzel, K.,
Goerz, G.,
and Scharffetter-Kochanek, K.
(1993)
Exp. Dermatol.
2,
92-97
|
| 49.
|
Conca, W.,
Kaplan, P. B.,
and Krane, S. M.
(1989)
J. Clin. Invest.
83,
1753-1757
|
| 50.
|
Angel, P.,
Baumann, I.,
Stein, B.,
Delius, J.,
Rahmsdorf, H. J.,
and Herrlich, P.
(1987)
Mol. Cell. Biol.
7,
2256-2266[Abstract/Free Full Text]
|
| 51.
|
Stein, B.,
Rahmsdorf, H. J.,
Steffen, A.,
Litfin, M.,
and Herrlich, P.
(1989)
Mol. Cell. Biol.
9,
5169-5181[Abstract/Free Full Text]
|
| 52.
|
Brenneisen, P.,
Wenk, J.,
Klotz, L. O.,
Wlaschek, M.,
Briviba, K.,
Krieg, T.,
Sies, H.,
and Scharffetter-Kochanek, K.
(1998)
J. Biol. Chem.
273,
5279-5287[Abstract/Free Full Text]
|
| 53.
|
Tyrrell, R. M.,
and Pidoux, M.
(1987)
Cancer Res.
47,
1825-1829[Abstract/Free Full Text]
|
| 54.
|
Stetler-Stevenson, W. G.,
Hewitt, R.,
and Corcoran, M.
(1996)
Semin. Cancer Biol.
7,
147-154[CrossRef][Medline]
[Order article via Infotrieve]
|
| 55.
|
Scharffetter-Kochanek, K.,
Wlaschek, M.,
Bolsen, K.,
Herrmann, G.,
Lehmann, P.,
Goerz, G.,
Mauch, C.,
and Plewig, G.
(1992)
in
The Environmental Threat of the Skin
(Plewig, G.
, and Marks, R., eds)
, pp. 77-82, Martin Dunitz Publishers, London
|
| 56.
|
Majmudar, G.,
Nelson, B. R.,
Jensen, T. C.,
Voorhees, J. J.,
and Johnson, T. M.
(1994)
Mol. Carcinogen.
9,
17-23[Medline]
[Order article via Infotrieve]
|
| 57. |